NDC 0169-6432

Levemir

Insulin Detemir

Levemir is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Detemir.

• Product ID: 0169-6432_40c85e9f-5e3e-4f53-a642-1ee982273108
• NDC: 0169-6432
• Product Type: Human Prescription Drug
• Proprietary Name: Levemir
• Generic Name: Insulin Detemir
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2013-10-31
• Marketing Category: BLA /
• Application Number: BLA021536
• Labeler Name: Novo Nordisk
• Substance Name: INSULIN DETEMIR
• Active Ingredient Strength: 100 [iU]/mL
• Pharm Classes: Insulin Analog [EPC], Insulin [Chemical/Ingredient]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0169-6432-10

5 SYRINGE, PLASTIC in 1 CARTON (0169-6432-10) > 3 mL in 1 SYRINGE, PLASTIC (0169-6432-55)

• Marketing Start Date: 2022-12-02
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Levemir" or generic name "Insulin Detemir"

NDC	Brand Name	Generic Name
0169-3687	Levemir	insulin detemir
0169-6432	Levemir	insulin detemir
0169-6438	Levemir	insulin detemir
50090-1276	Levemir	insulin detemir
50090-1475	Levemir	insulin detemir
50090-4501	Levemir	insulin detemir
68258-8977	Levemir	insulin detemir
70518-1387	Levemir	insulin detemir
70518-1462	Levemir	insulin detemir